| Literature DB >> 33716751 |
Yugal Goel1, Saveg Yadav1, Shrish Kumar Pandey1, Mithlesh Kumar Temre1, Vinay Kumar Singh2, Ajay Kumar3, Sukh Mahendra Singh1.
Abstract
Methyl jasmonate (MJ) displays antineoplastic potential against numerous neoplastic cells. However, several mechanistic aspects of its antineoplastic action against malignancies of T cell origin remain elusive. The present investigation reports the novel targets of MJ and mechanistic pathways of MJ-mediated antineoplastic and chemosensitizing action against tumor cells derived from murine T-cell lymphoma, designated as Dalton's lymphoma (DL). The present study demonstrates that MJ directly docks to HIF-1α, hexokinase 2, and Hsp70 at prominent binding sites. MJ exhibits tumoricidal action against tumor cells via induction of apoptosis and necrosis through multiple pathways, including declined mitochondrial membrane potential, enhanced expression of ROS, altered pH homeostasis, an elevated level of cytosolic cytochrome c, and modulated expression of crucial cell survival and metabolism regulatory molecules. Additionally, this study also reports the chemosensitizing ability of MJ against T cell lymphoma accompanied by a declined expression of MDR1. This study sheds new light by demonstrating the implication of novel molecular mechanisms underlying the antitumor action of MJ against T-cell lymphoma and hence has immense translational significance.Entities:
Keywords: chemosensitivitiy; metabolism; methyl jasmonate; pH homeostasis; tumor cytotoxicity
Year: 2021 PMID: 33716751 PMCID: PMC7954117 DOI: 10.3389/fphar.2021.628329
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810